Reduced alpha diversity of the oral microbiome correlates with short progression‐free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib‐based therapy (AGMT MM 1, phase II trial)

Abstract Alterations in the human microbiome have been linked to several malignant diseases. Here, we investigated the oral microbiome of 79 patients with relapsed/refractory multiple myeloma (MM) treated with ixazomib‐thalidomide‐dexamethasone. Increased alpha diversity (Shannon index) at the phylu...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Heinz Ludwig, Bela Hausmann, Martin Schreder, Wolfram Pönisch, Niklas Zojer, Stefan Knop, Eberhard Gunsilius, Alexander Egle, Andreas Petzer, Hermann Einsele, Roman Hajek, Katja Weisel, Karl Jochen Krenosz, Alois Lang, Daniel Lechner, Richard Greil, David Berry
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2021-02-01
coleção:	eJHaem
Assuntos:	molecular analysis mucosal multiple myeloma
Acesso em linha:	https://doi.org/10.1002/jha2.130
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!